Literature DB >> 24163389

Metabolic syndrome and the risk of suicide: a community-based integrated screening samples cohort study.

Jung-Chen Chang1, Amy Ming-Fang Yen, Chau-Shoun Lee, Sam Li-Sheng Chen, Sherry Yueh-Hsia Chiu, Jean Ching-Yuan Fann, Hsiu-Hsi Chen.   

Abstract

OBJECTIVE: Metabolic syndrome (MetS) is reportedly associated with mental disorders that are known to increase the risk of suicide. However, it is not known whether this association is independent of other risk indicators of suicide. This study therefore investigated whether metabolic abnormalities increase the risk of suicide during a 10-year follow-up period.
METHODS: This prospective study enrolled participants from a community-based integrated screening samples cohort in Taiwan. Of the 76,297 people recruited for this study, 12,094 had MetS at baseline. The independent variables were MetS and its components such as high blood pressure and high blood lipid levels. The outcome was death from suicide (n = 146).
RESULTS: MetS was associated with an increased risk of suicide risk by 16% per MetS component (95% confidence interval [CI] = 1%-33%), adjusting for demographics, life-style factors, and clinical correlates. Of the five MetS components, elevated blood pressure was independently associated with suicide-related mortality (adjusted hazard ratio [aHR] = 1.49, 95% CI = 1.03-2.15).
CONCLUSIONS: This analysis of community-based longitudinal data showed that MetS and its components, particularly elevated blood pressure, correlated positively with suicide risk after controlling other factors. Therefore, public mental health interventions targeting suicide reduction may need to specifically focus on individuals with hypertension and other components of the MetS.

Entities:  

Keywords:  blood pressure; community-based integrated screening samples; hypertension; metabolic syndrome; mood disorders; suicide

Mesh:

Year:  2013        PMID: 24163389     DOI: 10.1097/PSY.0000000000000014

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  6 in total

1.  Independent and joint association of obesity and metabolic syndrome with depression and inflammation.

Authors:  Kasra Moazzami; Bruno B Lima; Samaah Sullivan; Amit Shah; J Douglas Bremner; Viola Vaccarino
Journal:  Health Psychol       Date:  2019-05-23       Impact factor: 4.267

2.  Distinct patterns of altered quantitative T1ρ and functional BOLD response associated with history of suicide attempts in bipolar disorder.

Authors:  Joseph J Shaffer; Virginia Willour; Jess G Fiedorowicz; Gary E Christensen; Jeffrey D Long; Casey P Johnson; Samantha L Schmitz; Aislinn J Williams; John Wemmie; Vincent A Magnotta
Journal:  Brain Imaging Behav       Date:  2021-10-02       Impact factor: 3.224

3.  Comorbid diseases as risk factors for incident posttraumatic stress disorder (PTSD) in a large community cohort (KCIS no.PSY4).

Authors:  Jung-Chen Chang; Amy Ming-Fang Yen; Hsiu-Hsi Chen; Sam Li-Sheng Chen; Sherry Yueh-Hsia Chiu; Jean Ching-Yuan Fann; Chau-Shoun Lee
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

4.  Potential metabolic monitoring indicators of suicide attempts in first episode and drug naive young patients with major depressive disorder: a cross-sectional study.

Authors:  Ke Zhao; Siyao Zhou; Xiang Shi; Jianjun Chen; Yaoyao Zhang; Kaili Fan; Xiangyang Zhang; Wei Wang; Wei Tang
Journal:  BMC Psychiatry       Date:  2020-07-28       Impact factor: 3.630

5.  Metabolic syndrome and psychiatric disorders: a population-based study.

Authors:  Fernanda Pedrotti Moreira; Karen Jansen; Taiane de A Cardoso; Thaíse C Mondin; Pedro V Magalhães; Flavio Kapczinski; Luciano D M Souza; Ricardo A da Silva; Jean Pierre Oses; Carolina D Wiener
Journal:  Braz J Psychiatry       Date:  2018-10-11       Impact factor: 2.697

6.  Mental health assessment in health checks of participants aged 30-49 years: A large-scale cohort study.

Authors:  Christine Geyti; Helle Terkildsen Maindal; Else-Marie Dalsgaard; Kaj Sparle Christensen; Annelli Sandbæk
Journal:  Prev Med Rep       Date:  2018-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.